CEREVEL THERAPEUTICS HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.47 USD | +0.95% |
|
+0.62% | +0.17% |
| 18/04 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
| 18/04 | Cerevel Therapeutics' Potential Parkinson's Treatment Meets Primary Endpoint in Phase 3 Study | MT |
Chart calendar Cerevel Therapeutics Holdings, Inc.
96694375f01c5c3b8b509.tOuBbUl2Al433TzGyMfbyB6xFlO4hCA9uamQh4tC1jY.35nzHn4xZQxQqHnxh_aWgVHJdSXS61dy9-vZ0Ll1mlDNv9gYDBhUa3ORTw~5a92dbc5313a978d4afbf76fc4e80986
Upcoming events on Cerevel Therapeutics Holdings, Inc.
Past events on Cerevel Therapeutics Holdings, Inc.
| 16/02/2024 07:30 pm | Extraordinary Shareholders Meeting |
| 30/11/2023 07:40 pm | Evercore ISI HealthCONx Conference |
| 14/11/2023 02:30 pm | Jefferies London Healthcare Conference |
| 01/11/2023 05:30 pm | Q3 2023 Earnings Call |
| 01/11/2023 04:00 pm | Q3 2023 Earnings Release |
| 12/09/2023 07:00 pm | Morgan Stanley Global Healthcare Conference - Fireside Chat |
| 02/08/2023 05:30 pm | Q2 2023 Earnings Call |
| 02/08/2023 04:00 pm | Q2 2023 Earnings Release |
| 07/06/2023 06:30 pm | Annual General Meeting |
| 10/05/2023 10:30 pm | Bank of America Healthcare Conference |
| 03/05/2023 05:30 pm | Q1 2023 Earnings Call |
| 03/05/2023 04:00 pm | Q1 2023 Earnings Release |
| 29/03/2023 08:00 pm | Stifel CNS Day |
| 06/03/2023 07:40 pm | Cowen Health Care Conference |
| 22/02/2023 06:30 pm | FY 2022 Earnings Call |
| 22/02/2023 05:00 pm | FY 2022 Earnings Release |
| 10/01/2023 09:45 pm | JP Morgan Healthcare Conference |
| 30/11/2022 02:00 am | Evercore ISI HealthCONx Conference |
| 17/11/2022 01:30 am | Stifel Healthcare Conference |
| 15/11/2022 | Guggenheim Healthcare Talks Immunology & Neurology Day |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -149 -146 -1.63% | -217 -207 -5.1% | -363 -349 -4.11% | -442 -417 -5.92% | -458 |
|
EBIT Million USD | Released Forecast Spread | -149 -152 1.77% | -220 -211 -4.33% | -368 -358 -2.78% | -447 -421 -6.3% | -483 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -152 -166 8.17% | -225 -222 -1.41% | -351 -356 1.27% | -432 -404 -7.02% | -448 |
|
Net income Million USD | Released Forecast Spread | -152 -166 8.18% | -225 -222 -1.38% | -352 -356 1.14% | -433 -405 -6.9% | -456 |
|
EPS USD | Released Forecast Spread | -2,01 -3,97 49.37% | -1,65 -1,61 -2.37% | -2,32 -2,35 1.1% | -2,67 -2,50 -6.61% | -2,49 |
| Announcement Date | 24/03/21 | 01/03/22 | 22/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -93,8 -93,3 -0.53% | -106 -94,4 -12.24% | -110 -104 -5.27% | -138 -108 -27.83% | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -64,5 -55,5 -16.23% | -72,5 -62,5 -15.96% | -93,0 -70,9 -31.1% | -95,1 -93,3 -1.86% | -107 -100 -6.89% | -99,6 -109 8.39% | -96,8 -109 10.84% | -111 -103 -7.61% | -140 -113 -23.37% | -119 | -120 | -123 | -127 | -125 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -59,1 -57,3 -3.04% | -68,3 -64,3 -6.16% | -90,5 -74,1 -22.15% | -99,9 -94,7 -5.55% | -92,6 -98,1 5.54% | -104 -110 5.61% | -99,4 -111 10.17% | -96,2 -103 6.56% | -132 -104 -27.18% | -110 | -109 | -113 | -115 | -123 |
|
Net income Million USD | Released Forecast Spread | -59,1 -57,3 -3.04% | -68,3 -65,1 -4.89% | -90,5 -74,4 -21.58% | -99,9 -96,0 -4.1% | -92,8 -97,5 4.83% | -104 -106 1.61% | -99,5 -109 8.9% | -96,4 -102 5.78% | -133 -105 -26.66% | -110 | -109 | -113 | -115 | -123 |
|
EPS USD | Released Forecast Spread | -0,40 -0,39 -1.42% | -0,46 -0,42 -9.63% | -0,61 -0,48 -27.88% | -0,66 -0,62 -6.48% | -0,59 -0,62 5.45% | -0,67 -0,67 0.72% | -0,63 -0,69 8.32% | -0,61 -0,65 5.83% | -0,76 -0,60 -26.62% | -0,61 | -0,60 | -0,63 | -0,62 | -0,72 |
| Announcement Date | 01/03/22 | 10/05/22 | 01/08/22 | 08/11/22 | 22/02/23 | 03/05/23 | 02/08/23 | 01/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Cerevel Therapeutics Holdings, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CERE Stock
- Calendar Cerevel Therapeutics Holdings, Inc.
